Ticker
RNAZCompany Name
TRANSCODE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 9.21M | $ 18.38M | $ 0 | $ 0 | -199.56% |
3/31/2025 | $ 8.09M | $ 19.17M | $ 0 | $ 0 | -236.86% |
12/31/2024 | $ 9.29M | $ 16.4M | $ 0 | $ 0 | -176.55% |
9/30/2024 | $ 6.04M | $ 10.3M | $ 0 | $ 0 | -170.45% |
6/30/2024 | $ 3.93M | $ 15.11M | $ 0 | $ 0 | -383.89% |
3/31/2024 | $ 5.34M | $ 20.82M | $ 0 | $ 0 | -389.7% |
12/31/2023 | $ 4.02M | $ 15.91M | $ 0 | $ 0 | -395.82% |
9/30/2023 | $ 6.37M | $ 14.93M | $ 0 | $ 0 | -234.26% |
6/30/2023 | $ 3.35M | $ 7.68M | $ 0 | $ 0 | -228.86% |
3/31/2023 | $ 5.17M | $ 1.18M | $ 0 | $ 0 | -22.82% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for TRANSCODE THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 1.19M ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2023
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |